Legend Biotech USA, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Legend Biotech USA, Inc. - overview
Established
2014
Location
Somerset, NJ, US
Primary Industry
Biotechnology
About
Founded in 2014 and based in New Jersey, US, Legend Biotech USA, Inc. is a biotech company that focuses on the development of tumor cell immunotherapy. In 2020, the company was listed on the NASDAQ. Its ticker symbol is LEGN.
In May 2023, Hillhouse Capital Group invested in Legend Biotech USA, Inc. for USD 12. 7 million. Ying Huang, the company's CEO, also serves as a board member of the company and Quanta Therapeutics.
He has more than 9 years of R&D background in large multinational pharmaceutical companies and 12 years of experience as a biotech analyst on Wall Street. In May 2023, returning investor Hillhouse Capital Group invested in Legend Biotech USA, Inc. for USD 22. 2 million.
The company's R&D pipeline mainly includes small cell lung cancer DLL3, multiple myeloma BCMA and hepatocellular carcinoma GPC3, etc. It has developed CAR-T therapy targeting CD38 and BCMA for the treatment of multiple myeloma. Its products are used to treat diseases such as blood cancers and lymphomas.
Current Investors
OFI Invest Asset Management, SignatureFD, Blue Trust
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.legendbiotech.com
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
Legend Biotech USA, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PIPE | Completed | Legend Biotech USA, Inc. | - | ||||||||
| PIPE | Completed | Legend Biotech USA, Inc. | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.